Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal factors may affect female hair loss, needing further research and treatment ideas.

HAIR-AN syndrome mainly affects obese women and can be improved with early diagnosis and treatment using insulin-sensitizing agents.

Some overweight or obese men with long-term frontal fibrosing alopecia may have abnormal sex hormone levels.

Women of reproductive age with polycystic ovary syndrome often experience hair loss.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Pharmacy workers need more education to better help people with hair loss.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

Early diagnosis and personalized treatment are crucial for managing pediatric androgenetic alopecia.

Female pattern hair loss in women can be due to hormones or aging.

Dissecting cellulitis of the scalp is a condition that causes inflammation and scarring on the scalp, mainly affecting African-American men, and can lead to permanent hair loss.

The document focused on hair disorders, especially alopecia, and discussed treatments and impacts on quality of life.

Genetics, low estrogen, and low iron levels contribute to female hair loss, with specific scalp signs indicating severity.

PCOS is a hormonal disorder causing symptoms like excess hair, acne, irregular periods, and fertility issues.

Hormonal imbalances contribute to female hair loss, and trichoscopy is a useful diagnostic tool.

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Adolescents with hair loss show different hormone levels by sex and often have related metabolic issues.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

High serum DHT levels can help diagnose PCOS.

Acne and hair loss are not good indicators of hormone imbalance in PCOS, but excessive body hair is.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Males had more severe COVID-19 symptoms, but their risk of death was only slightly higher than females.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Subclinical hypothyroidism in women with PCOS affects thyroid and hormone interactions but not ovary structure.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.